3
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Completed
1
Sponsor Class
INDUSTRY
3
Study Type
Observational
3
Sponsor
Conditions
Pain
4
Breakthrough Cancer Pain
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma
1
Quality of Life
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Ovarian Neoplasms
1
Neuralgia
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Fentanyl
3
Nasal Sprays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Breakthrough Cancer Pain
×
Fentanyl
×
Clear all
NCT03895762
2022-05-05
OASIS
A.Menarini Asia-Pacific Holdings Pte Ltd
Completed
143 enrolled
NCT01693328
2014-01-15
Qualipec
Archimedes Development Ltd
Unknown
300 enrolled
NCT01698645
2013-07-11
Qualipec
Archimedes Development Ltd
Unknown
150 enrolled